NCT01496937View on ClinicalTrials.gov

First-in-Human Exploratory Single Ascending Dose of GLPG0974

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

February 29, 2012

Conditions

Healthy

Interventions

DRUG

GLPG0974

DRUG

GLPG0974

Trial Locations (1)

Unknown

SGS Stuivenberg, Antwerp

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galapagos NV

INDUSTRY